GlassScriptPhysician profile
Bruce L Jackson
NPI 1124072087
$1,344.58
in general payments reported to CMS, 2019-2025
20 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.59 · 2022: $485 · 2023: $206 · 2024: $194 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $445.87 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $138.96 | 2021-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $110.94 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.30 | 2023-2025 | |
| Pfizer INC. | $85.22 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $69.61 | 2021-2022 | |
| Exact Sciences Corporation | $49.80 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $37.46 | 2022-2023 | Farxiga |
| Redhill Biopharma INC. | $35.47 | 2025 | Talicia |
| Paratek Pharmaceuticals, INC. | $34.96 | 2025 | Xhance |
| Phadia US INC. | $34.93 | 2024-2025 | Immunocap |
| Sumitomo Pharma America, INC. | $32.58 | 2025 | Myfembree |
| Shield Therapeutics INC | $27.24 | 2025 | |
| Viiv Healthcare Company | $23.90 | 2025 | Apretude |
| Janssen Pharmaceuticals, INC | $23.58 | 2025 | Invega Sustenna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.76 | 2022 | |
| Amgen INC. | $22.69 | 2025 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.56 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.30 | 2021 | |
| Philips North America LLC | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.